- R75 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM R75 became effective on October 1, 2022.
- This is the American ICD-10-CM version of R75 – other international versions of ICD-10 R75 may differ.
ICD-10-CM R75 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Applicable To
- Nonconclusive HIV-test finding in infants
Type 1 Excludes
- asymptomatic human immunodeficiency virus [HIV] infection status (Z21)
- human immunodeficiency virus [HIV] disease (B20)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to R75:
- laboratory evidence (nonconclusive) > HIV B20
- nonconclusive test (in infants) > HIV B20
- laboratory evidence > immunodeficiency virus (HIV) disease (infection) B20
- test, human immunodeficiency virus (HIV) > Positive
- HIV (human immunodeficiency virus) > Test, tests, testing (for)
- nonconclusive (in infants) > HIV (human immunodeficiency virus) R75